Skin sensitization risk of medical devices (MDs) has to be assessed before their marketing and clinical use. The obligatory methods (ISO 10993-10:2021) include exclusively in vivo tests, however, validated non-animal methods might be utilized after successful ... ...

请注册登录后继续浏览